Tests target better treatment of lung infections
Lung infections are a constant risk for people living with cystic fibrosis (CF), a life-threatening genetic disorder which impairs lung function, predisposes people to persistent airway […]
Flinders ‘Winnovator’ battles Cystic Fibrosis through nanotech
Flinders researcher Melanie Fuller’s work in improving the efficiency of gene therapy in treating Cystic Fibrosis through nanotechnology has been recognised with a place in the finals of this year’s ‘Winnovation Awards’.